Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

S Sakai1, T Miyauchi, M Kobayashi

  • 1Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.

Nature
|November 28, 1996
PubMed

Insights

Blocking endothelin-1 receptors improved survival in rats with chronic heart failure. This treatment also reduced heart dysfunction and prevented adverse cardiac remodeling, suggesting a new therapeutic target for heart failure.

Area of Science:

  • Cardiovascular Biology
  • Heart Failure Pathophysiology
  • Endothelin System

Background:

  • Coronary artery occlusion leads to myocardial infarction, increasing chronic heart failure risk.
  • Endothelin-1, produced by cardiac myocytes and endothelial cells, enhances contractility but also causes hypertrophy and injury.
  • Elevated endothelin-1 in heart failure suggests a role in supporting cardiac function, but its long-term impact is debated.

Purpose of the Study:

  • To investigate the long-term effects of endothelin-receptor antagonism on chronic heart failure progression.
  • To determine if blocking the endothelin system could improve survival and cardiac function in a rat model of heart failure.

Main Methods:

  • Utilized a rat model of chronic heart failure following myocardial infarction.
  • Administered an endothelin-receptor antagonist over the long term.
  • Assessed survival rates, left ventricular function, and ventricular remodeling.

Main Results:

  • Long-term treatment with an endothelin-receptor antagonist significantly improved survival in rats with chronic heart failure.
  • The antagonist treatment led to a significant amelioration of left ventricular dysfunction.
  • Prevention of ventricular remodeling, characterized by reduced ventricular mass and cavity enlargement, was observed.

Conclusions:

  • Upregulation of the myocardial endothelin system contributes to the progression of chronic heart failure.
  • Long-term blockade of endothelin receptors offers a promising therapeutic strategy for improving outcomes in chronic heart failure.
  • Targeting the endothelin system may mitigate adverse cardiac remodeling and preserve cardiac function in heart failure.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...